Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics Analysis Identified the Hub Genes, mRNA-miRNA-lncRNA Axis, and Signaling Pathways Involved in Rheumatoid Arthritis Pathogenesis. | Int J Gen Med | 2022 | 35422654 | PubTator, text mining | PubMed |
| A Comparative Genomic Approach to Determine the Virulence Factors and Horizontal Gene Transfer Events of Clinical Acanthamoeba Isolates. | Microbiol Spectr | 2022 | 35416714 | PubTator, text mining | PubMed |
| MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2. | Cell Death Dis | 2022 | 35410462 | PubTator, text mining | PubMed |
| Expansion of the prime editing modality with Cas9 from Francisella novicida. | Genome Biol | 2022 | 35410288 | PubTator, text mining | PubMed |
| Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes. | Int J Mol Sci | 2022 | 35408909 | PubTator, text mining | PubMed |
| A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin. | Front Pharmacol | 2022 | 35401176 | PubTator, text mining | PubMed |
| SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding. | Sci Rep | 2022 | 35393453 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology. | Front Mol Biosci | 2022 | 35372513 | PubTator, text mining | PubMed |
| Multi-modality machine learning predicting Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35365675 | PubTator, text mining | PubMed |
| Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. | Front Pain Res (Lausanne) | 2022 | 35360655 | PubTator, text mining | PubMed |
| Drug Discovery of Plausible Lead Natural Compounds That Target the Insulin Signaling Pathway: Bioinformatics Approaches. | Evid Based Complement Alternat Med | 2022 | 35356248 | PubTator, text mining | PubMed |
| Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer. | Front Oncol | 2022 | 35330716 | PubTator, text mining | PubMed |
| Anti-Inflammatory Characteristics of Local Anesthetics: Inhibition of TNF-α Secretion of Lipopolysaccharide-Stimulated Leucocytes in Human Blood Samples. | Int J Mol Sci | 2022 | 35328706 | PubTator, text mining | PubMed |
| The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD. | Int J Mol Sci | 2022 | 35328704 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management. | Int J Mol Sci | 2022 | 35328669 | PubTator, text mining | PubMed |
| Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why? | Int J Mol Sci | 2022 | 35328597 | PubTator, text mining | PubMed |
| Candidate master microRNA regulator of arsenic-induced pancreatic beta cell impairment revealed by multi-omics analysis. | Arch Toxicol | 2022 | 35314868 | PubTator, text mining | PubMed |
| Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. | Hepatology | 2022 | 35313030 | PubTator, text mining | PubMed |
| SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis. | iScience | 2022 | 35310939 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=17